Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438627
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-24
Brief Title:
Efficacy and Safety of TPCApatinibCamrelizumab vs GP Camrelizumab for High-Risk Nasopharyngeal Carcinoma A Phase 3 Trial
Sponsor:
XIANG YANQUN
Organization:
Sun Yat-sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-24
First Submit QC Date:
May 30 2024
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-13
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL